On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The Leukemia & Lymphoma Society (LLS).

In partnership with Fred Hutchinson Cancer Research Center researchers, the grant was awarded to  improving adoptive cell therapies for patients with multiple myeloma and developing the next generation of promising myeloma therapies for patients.

The LLS SCOR grant program is intended to bring together established investigators from one or more institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisciplinary research among the participants.